ResMed Inc. vs Tidewater Inc — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Tidewater Inc trades at $78.18 (market cap $3.75B). The key difference: ResMed Inc. is far larger — about 7.7× Tidewater Inc's market cap, and ResMed Inc. pays a 1.21% dividend while Tidewater Inc pays none. Which is the better fit depends on your goals.
| RMD | TDW | |
|---|---|---|
Market Cap | $28.81B | $3.75B |
Sector | Health | Utilities |
52-Week High | $293.73 | $91.12 |
52-Week Low | $182.82 | $47.29 |
Enterprise Value | $27.99B | $3.85B |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →